Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Postgraduate Medical Journal|January 1, 1979
Cefaclor--summary of clinical experienceR B Kammer, L J ShortReviews of Infectious Diseases|November 1, 1982
Moxalactam: clinical summary of efficacy and safetyR B KammerDiagnostic Microbiology and Infectious Disease|January 1, 1991
Randomized comparative study of ceftibuten versus cefaclor in the treatment of acute lower respiratory tract infectionsR B Kammer, R RessAmerican Journal of Infection Control|December 1, 1993
Risk of occupational infection with blood-borne pathogens in operating and delivery room settingsL J Short, D M BellThe Surgical Clinics of North America|December 1, 1995
How to select and evaluate new products on the marketE J Quebbeman, L J ShortAntimicrobial Agents and Chemotherapy|July 1, 1975
Rapid detection of ampicillin-resistant Haemophilus influenzae and their susceptibility to sixteen antibioticsR B Kammer, D A Preston, J R Turner, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug AdministrationA W Chow, C B Hall, J O Klein, et al.American Journal of Clinical Pathology|November 1, 1979
In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center studyA L Barry, F D Schoenknect, S Shadomy, et al.Antimicrobial Agents and Chemotherapy|January 1, 1979
Interpretive criteria for cefamandole and cephalothin disk diffusion susceptibility testsA L Barry, F D Schoenknecht, S Shadomy, et al.Pageof 2